Literature DB >> 2614688

Fitting heteroscedastic regression models to individual pharmacokinetic data using standard statistical software.

D M Giltinan1, D Ruppert.   

Abstract

In the analysis of individual pharmacokinetic data by nonlinear regression it is important to allow for possible heterogeneity of variance in the response. Two common methods of doing this are weighted least squares with appropriate weights or data transformation using a suitable transform. With either approach it is appealing to let the data determine the appropriate choice of weighting scheme or transformation. This article describes two methods of doing this which are easy to compute using standard statistical software. The first method is a generalized least squares scheme for the case where the variance is assumed proportional to an unknown power of the mean. The second involves applying a power transformation to both sides of the regression equation. It is shown that both techniques may be implemented using only nonlinear regression routines. Sample code is provided for their implementation using the SAS software package. However, the proposed methods are feasible using any software package that incorporates a nonlinear least squares routine, and are thus well suited to routine use.

Mesh:

Substances:

Year:  1989        PMID: 2614688     DOI: 10.1007/bf01071352

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  4 in total

Review 1.  Use and abuse of variance models in regression.

Authors:  J C van Houwelingen
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

2.  Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man.

Authors:  S A Kaplan; R E Weinfeld; C W Abruzzo; M Lewis
Journal:  J Pharm Sci       Date:  1972-05       Impact factor: 3.534

3.  Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data.

Authors:  C C Peck; S L Beal; L B Sheiner; A I Nichols
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

4.  Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1985-04
  4 in total
  8 in total

1.  A comparison of methods for estimating individual pharmacokinetic parameters.

Authors:  T Amisaki; S Eguchi
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

2.  Optimal design for estimating parameters of the 4-parameter hill model.

Authors:  Leonid A Khinkis; Laurence Levasseur; Hélène Faessel; William R Greco
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-07

3.  D-optimal designs for parameter estimation for indirect pharmacodynamic response models.

Authors:  Leonid A Khinkis; Wojciech Krzyzanski; William J Jusko; William R Greco
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-11-11       Impact factor: 2.745

4.  Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses: noncompartmental approach and compartmental modeling.

Authors:  F Mesnil; C Dubruc; F Mentre; S Huet; A Mallet; J P Thenot
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

5.  Fitting nonlinear regression models with correlated errors to individual pharmacodynamic data using SAS software.

Authors:  R Bender; L Heinemann
Journal:  J Pharmacokinet Biopharm       Date:  1995-02

6.  Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Anna Leonidova; Mireille Vargas; Jörg Huwyler; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys.

Authors:  C A Rodriguez; D E Smith
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

8.  A strategy for residual error modeling incorporating scedasticity of variance and distribution shape.

Authors:  Anne-Gaëlle Dosne; Martin Bergstrand; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-12-17       Impact factor: 2.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.